Company ANGLE plc

Equities

AGL

GB0034330679

Advanced Medical Equipment & Technology

Market Closed - London S.E. 12:35:17 2024-03-28 pm EDT 5-day change 1st Jan Change
12.5 GBX +2.04% Intraday chart for ANGLE plc -5.66% +6.38%

Business Summary

ANGLE plc is a United Kingdom-based liquid biopsy company. The Company is engaged in the development and commercialization of the Parsortix cell separation system, with deployment in liquid biopsy-non-invasive cancer diagnostics. Its platforms include an epitope-independent circulating tumor cell (CTC) harvesting technology and a downstream analysis system for highly multiplexed analysis of nucleic acids and proteins. Its Parsortix PC1 Clinical system captures and harvests circulating CTCs from metastatic breast cancer patients blood for subsequent, user-validated analysis. The Parsortix PC1 Clinical System is a liquid biopsy technology. Its labs in Guildford provide specialist CTC enrichment and analysis services to support translational research studies and pharmaceutical trials. It has developed the Parsortix system, including instruments and one-time use cassettes that can be sold to third-party laboratories for their use in research, pharmaceutical development, or clinical use.

Sales per Business

GBP in Million2021Weight2022Weight Delta
Product
57.1 %
1 77.0 % 1 57.1 % -23.85%
Pharma Service
32.2 %
0 16.1 % 0 32.2 % +105.52%
Product Service
10.8 %
0 6.9 % 0 10.8 % +60.00%

Sales per region

GBP in Million2021Weight2022Weight Delta
Europe
44.8 %
1 69.3 % 0 44.8 % -33.62%
North America - Rest of World
34.0 %
0 22.0 % 0 34.0 % +58.74%
United Kingdom
21.2 %
0 8.7 % 0 21.2 % +151.14%

Managers

Managers TitleAgeSince
Founder 63 94-03-31
Director of Finance/CFO - 94-12-31
Chief Tech/Sci/R&D Officer - 23-06-04
Chief Tech/Sci/R&D Officer - 14-03-31
Chief Tech/Sci/R&D Officer - 16-10-31
Chief Tech/Sci/R&D Officer - 16-02-29
Investor Relations Contact - 20-12-31
Corporate Officer/Principal - -
Corporate Officer/Principal - 19-10-31
Corporate Officer/Principal - -

Members of the board

Members of the board TitleAgeSince
Director of Finance/CFO - 94-12-31
Founder 63 94-03-31
Director/Board Member 80 13-01-06
Chairman 65 18-10-31
Director/Board Member 57 23-01-04
Director/Board Member 56 23-01-18

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 260,580,547 232,596,523 ( 89.26 %) 0 89.26 %

Shareholders

NameEquities%Valuation
Conifer Realty LLC
7.667 %
19,979,790 7.667 % 4 M p
Global Frontier Investments LLC
6.474 %
16,868,946 6.474 % 3 M p
12,777,088 4.903 % 3 M p
Hargreaves Lansdown Asset Management Ltd.
3.655 %
9,525,000 3.655 % 2 M p
Baillie Gifford & Co.
3.090 %
8,051,990 3.090 % 2 M p
Chelverton Asset Management Ltd.
2.878 %
7,500,000 2.878 % 2 M p
7,304,696 2.803 % 1 M p
Global Prime Partners Ltd.
2.085 %
5,433,000 2.085 % 1 M p
Aegon Asset Management UK PLC
2.029 %
5,287,903 2.029 % 1 M p
IG Markets Ltd.
1.317 %
3,433,000 1.317 % 690 479 p

Company contact information

ANGLE Plc

The Surrey Research Park 10 Nugent Road

GU2 7AF, Guildford

+44 14 8334 3434

http://www.angleplc.com
address ANGLE plc(AGL)